Filter
548
Filtered Results: 548
Text search:
World
Health
Organization
(WHO),
Ministry
of
Health,
DR
Congo
Featured
Recommendations
56
New Publications
204
Language
Document type
No document type
375
Studies & Reports
87
Guidelines
37
Strategic & Response Plan
18
Manuals
17
Situation Updates
7
Training Material
5
Resource Platforms
1
Infographics
1
Countries / Regions
Congo, Democratic Republic of
47
Sierra Leone
24
Uganda
24
India
22
Zambia
22
Liberia
21
Africa
20
Nigeria
17
Ethiopia
16
Kenya
16
Tanzania
14
Rwanda
14
Global
13
Guinea
10
Ghana
10
East and Southern Africa
10
Zimbabwe
9
Malawi
8
Myanmar / Burma
8
Bangladesh
7
Mozambique
7
West and Central Africa
7
Western and Central Europe
7
South Sudan
6
Central African Republic
6
Burkina Faso
5
Senegal
4
Cameroon
4
Nepal
4
Afghanistan
4
Cambodia
4
South Africa
4
Benin
4
Eswatini/ Swaziland
4
Latin America and the Carribbean
4
Haiti
3
Syria
3
Namibia
3
Lesotho
3
Eastern Europe
3
Mali
2
Germany
2
Indonesia
2
North Macedonia
2
Colombia
2
Angola
2
Yemen
2
Asia
2
Southern Africa
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Togo
1
Philippines
1
Somalia
1
Pakistan
1
Iraq
1
Chad
1
China
1
Sudan
1
Ukraine
1
Botswana
1
Madagascar
1
Mexico
1
South–East Asia Region
1
Paraguay
1
Fiji
1
Venezuela
1
Palestine
1
Congo-Brazzaville
1
Kyrgyzstan
1
North America
1
Turkmenistan
1
Jamaica
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
241
Clinical Guidelines
41
Public Health
31
Women & Child Health
30
Key Resources
16
Capacity Building
9
Pharmacy & Technologies
3
Annual Report MEDBOX
1
Toolboxes
Ebola
59
TB
43
Rapid Response
33
HIV
28
NTDs
25
COVID-19
21
Mental Health
18
Planetary Health
15
Conflict
13
Disability
11
Pharmacy
11
Global Health Education
10
Caregiver
7
Health Financing Toolbox
7
Refugee
6
Cholera
4
Specific Hazards
4
AMR
4
Polio
3
Natural Hazards
1
Zika
1
Social Ethics
1
NCDs
1
15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19.
The specific objectives ... the analysis were to:
describe the clinical characteristics and outcomes of PLHIV hospitalized for COVID-19
assess whether PLHIV hospitalized with COVID-19 were at increased risk of presenting with severe or critical illness at admission and were at increased risk of in-hospital death compared to individuals not infected with HIV
assess risk factors associated with severe or critical illness at hospital admission and of in-hospital death among PLHIV hospitalized for COVID-19.
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing ... initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills m...
This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and ... technical staff involved in the eradication of yaws.
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on sa...
January 2020 to December 2021
The Guidelines for the Diagnosis, Treatment and Prevention of Leprosy provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public ... approach in endemic countries. The target audience of this document includes policy-makers in leprosy or infectious diseases in the ministries of health (especially but not limited to endemic countries), nongovernmental organizations, clinicians, pharmaceutical companies, donors and affected persons
Technical Report
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of t...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health ....
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme planning and prioritization – user guide, pu...
This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation ... yaws eradication activities and WHO technical staff who provide technical support to countries in the eradication of yaws.
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of...
Since the beginning of December a significant increase in the incidence of new cases has been observed particularly along the corridor towards the large urban center ... Butembo (health zones of Butembo and Katwa) and beyond in the zone of Kayna health center located about 150 km from Goma. In addition, active outbreaks have emerged to the north, particularly in the health zones of Komanda and Oicha.
The third strategic response plan (SRP-3), which covers February through end July 2019, considers the salient points and recommendations made during the operational review of the implementation of the SRP-2 and other guidance based on lessons learned and risk analysis.
The 2016-2017 Biennial report presents an overview of WHO Namibia's main achievements and challenges and highlights its vision for the next five years.
The World Health Organization (WHO) convened a meeting ... the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact ... COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the importance of diagnosis and drug susceptibility testing, a focus onstrengthening laboratory networks and the regional laboratory and diagnostic objectives. A brief update of the state of the science and how this is funded across the African region is provided, before closing with challenges and opportunities,strategic directions and a brief discussion of funding concerns. Discussions around the drivers of the disease, and issues of the poverty, inequality and stigma that continue to plague those living with TB are fully recognized, but are outside the scope of this report.
This analytical report reviews and discusses the potential role and influence of political commitment in implementing endorsements and conducting policy in the field of tuberculosis (TB) prevention ...
